Evangelisches Krankenhaus Koeln-Weyertal, Weyertal 76, 50931 Cologne
Germany
Research Article
The Expression of the Thrombin Receptors PAR-3 and PAR-4 is Downregulated in Pancreatic Cancer Cell Lines
Author(s): Claudia Rudroff, Annette Richard, Sarah Hilswicht and Edmund AM NeugebauerClaudia Rudroff, Annette Richard, Sarah Hilswicht and Edmund AM Neugebauer
Background: Patients with pancreatic cancer frequently suffer from thrombosis as a consequence of excess thrombin generation. In addition to its role in the plasmatic coagulation cascade, thrombin induces numerous cellular effects by activating a unique group of G-protein-coupled receptors on the cell membrane, the proteinase-activated receptors (PARs). At present, PAR-1, PAR-3 and PAR-4 are known to be activated by thrombin. We previously demonstrated a putative role for PAR-1 in pancreatic cancer progression, but little is known about the physiological and pathophysiological roles of PAR-3 and PAR-4. In the present study, we examined the expression patterns of PAR-3 and PAR-4 in pancreatic tissue and pancreatic cancer cells.
Methods: Tissue samples from three patients with pancreatic .. Read More»
Journal of Surgery received 288 citations as per Google Scholar report